[
  {
    "gene_name": "BRAF",
    "variant_name": "V600E",
    "HGVScoding": "NM_004333.4:c.1799T>A",
    "HGVSprotein": "NP_004324.2:p.Val600Glu",
    "position": "GrCh37:chr7:140453136",
    "molecular_consequence": "NON_SYNONYMOUS",
    "dbSNP": "rs113488022",
    "SVIP_status": "Reviewed",
    "SVIP_confidence_score": 4,
    "diseases": [
      {
        "name": "Skin Melanoma",
        "nb_patients": 12,
        "tier_level": "Tier I",
        "age_distribution": {
          "<40": 0,
          "41-60": 3,
          "61-80": 9,
          ">80": 0
        },
        "gender_balance": {
          "male": 8,
          "female": 4
        },
        "pathogenicity": "",
        "pathogenicity_level": "expert",
        "SVIP_status": "Curated",
        "clinical_significance": "Predictive (Tier I)",
        "significance_label": "A",
        "score": 3,
        "evidences": [
          {
            "evidence_type": "Predictive",
            "clinical_significance": "Sensitive",
            "drug": "Vemurafenib",
            "tier_level": "Tier I",
            "reference": "PMID:21639808"
          }
        ]
      },
      {
        "name": "Papillary Thyroid Carcinoma",
        "nb_patients": 34,
        "tier_level": "Tier II",
        "age_distribution": {
          "<40": 12,
          "41-60": 9,
          "61-80": 10,
          ">80": 3
        },
        "gender_balance": {
          "male": 30,
          "female": 4
        },
        "pathogenicity": "Pathogenic",
        "pathogenicity_level": "automatic",
        "SVIP_status": "Reviewed",
        "clinical_significance": "Predictive (Tier II) / Prognostic (Tier II)",
        "significance_label": "B",
        "score": 4,
        "evidences": [
          {
            "evidence_type": "Prognostic",
            "clinical_significance": "Poor outcome",
            "drug": "",
            "tier_level": "Tier II",
            "reference": "PMID:24396464"
          },
          {
            "evidence_type": "Predictive",
            "clinical_significance": "Sensitive",
            "drug": "Vemurafenib",
            "tier_level": "Tier II",
            "reference": "PMID:27460442"
          },
          {
            "evidence_type": "In vitro assay",
            "clinical_significance": "Pathogenic",
            "drug": "",
            "tier_level": "",
            "reference": "PMID:15035987"
          }
        ]
      },
      {
        "name": "Colorectal Cancer"
      }
    ]
  },
  {
    "gene_name": "BRAF",
    "variant_name": "G596R",
    "HGVScoding": "NM_004333.4:c.1786G>C",
    "HGVSprotein": "NP_004324.2:p.Gly596Arg",
    "position": "GrCh37:chr7:140453149",
    "molecular_consequence": "NON_SYNONYMOUS",
    "tier_level": 3,
    "dbSNP": "rs121913361",
    "SVIP_status": "Loaded",
    "SVIP_confidence_score": 2,
    "diseases": [
      {
        "name": "Colorectal Cancer",
        "nb_patients": 25,
        "tier_level": "Tier II",
        "age_distribution": {
          "<40": 1,
          "41-60": 3,
          "61-80": 19,
          ">80": 2
        },
        "gender_balance": {
          "male": 10,
          "female": 15
        },
        "pathogenicity": "",
        "pathogenicity_level": "expert",
        "SVIP_status": "Curated",
        "clinical_significance": "Predictive (Tier II)",
        "significance_label": "A",
        "score": 2,
        "evidences": [
          {
            "evidence_type": "Predictive",
            "clinical_significance": "Resistance",
            "drug": "Vemurafenib",
            "tier_level": "Tier II",
            "reference": "PMID:22180495"
          }
        ]
      }
    ]
  },
  {
    "gene_name": "BRAF",
    "variant_name": "K601E",
    "HGVScoding": "NM_004333.4:c.1801A>G",
    "HGVSprotein": "NP_004324.2:p.Lys601Glu",
    "position": "GrCh37:chr7:140453134",
    "molecular_consequence": "NON_SYNONYMOUS",
    "tier_level": 2,
    "dbSNP": "rs121913364",
    "SVIP_status": "Curated",
    "SVIP_confidence_score": 3,
    "diseases": [
      {
        "name": "Skin Melanoma",
        "nb_patients": 12,
        "tier_level": "Tier II",
        "age_distribution": {
          "<40": 0,
          "41-60": 3,
          "61-80": 9,
          ">80": 0
        },
        "gender_balance": {
          "male": 12,
          "female": 0
        },
        "pathogenicity": "",
        "pathogenicity_level": "automatic",
        "SVIP_status": "Curated",
        "clinical_significance": "Predictive (Tier II)",
        "significance_label": "B",
        "score": 2,
        "evidences": [
          {
            "evidence_type": "Predictive",
            "clinical_significance": "Sensitive",
            "drug": "Dabrafenib",
            "tier_level": "Tier II",
            "reference": "PMID:21343559"
          }
        ]
      }
    ]
  },
  {
    "gene_name": "EGFR",
    "variant_name": "L858R",
    "HGVScoding": "NM_005228.4:c.2573T>G",
    "HGVSprotein": "NP_005219.2:p.Leu858Arg",
    "position": "GrCh37:chr7:55259515",
    "molecular_consequence": "NON_SYNONYMOUS",
    "dbSNP": "rs121434568",
    "SVIP_status": "Reviewed",
    "SVIP_confidence_score": 3,
    "diseases": [
      {
        "name": "Non-Small Cell Lung Carcinoma",
        "nb_patients": 88,
        "tier_level": "Tier II",
        "age_distribution": {
          "<40": 4,
          "41-60": 31,
          "61-80": 40,
          ">80": 15
        },
        "gender_balance": {
          "male": 44,
          "female": 44
        },
        "pathogenicity": "",
        "pathogenicity_level": "automatic",
        "SVIP_status": "Reviewed",
        "clinical_significance": "Predictive (Tier I) / Prognostic (Tier II)",
        "significance_label": "B",
        "score": 3,
        "evidences": [
          {
            "evidence_type": "Prognostic",
            "clinical_significance": "Poor outcome",
            "drug": "",
            "tier_level": "Tier II",
            "reference": "PMID:24662454"
          },
          {
            "evidence_type": "Predictive",
            "clinical_significance": "Sensitive",
            "drug": "Erlotinib",
            "tier_level": "Tier I",
            "reference": "PMID:24868098"
          }
        ]
      },
      {
        "name": "Lung Adenocarcinoma",
        "nb_patients": 56,
        "tier_level": "Tier I",
        "age_distribution": {
          "<40": 10,
          "41-60": 23,
          "61-80": 18,
          ">80": 5
        },
        "gender_balance": {
          "male": 30,
          "female": 26
        },
        "pathogenicity": "Pathogenic",
        "pathogenicity_level": "expert",
        "SVIP_status": "Reviewed",
        "clinical_significance": "Predictive (Tier I)",
        "significance_label": "A",
        "score": 4,
        "evidences": [
          {
            "drug": "Afatinib",
            "evidence_type": "Predictive",
            "clinical_significance": "Sensitive",
            "tier_level": "Tier I",
            "reference": "PMID:29141884"
          },
          {
            "drug": "",
            "evidence_type": "In vitro assay",
            "clinical_significance": "Pathogenic",
            "tier_level": "",
            "reference": "PMID:29141884"
          }
        ]
      }
    ]
  },
  {
    "gene_name": "EGFR",
    "variant_name": "S768I",
    "HGVScoding": "NM_005228.4:c.2303G>T",
    "HGVSprotein": "NP_005219.2:p.Ser768Ile",
    "position": "GrCh37:chr7:55249005",
    "molecular_consequence": "NON_SYNONYMOUS, NONCODING_CHANGE",
    "dbSNP": "rs121913465",
    "SVIP_status": "Curated",
    "SVIP_confidence_score": 4,
    "diseases": [
      {
        "name": "Non-Small Cell Lung Carcinoma",
        "nb_patients": 12,
        "tier_level": "Tier I",
        "age_distribution": {
          "<40": 0,
          "41-60": 2,
          "61-80": 8,
          ">80": 2
        },
        "gender_balance": {
          "male": 4,
          "female": 8
        },
        "pathogenicity": "",
        "pathogenicity_level": "automatic",
        "SVIP_status": "Curated",
        "clinical_significance": "Predictive (Tier I)",
        "significance_label": "B",
        "score": 2,
        "evidences": [
          {
            "evidence_type": "Predictive",
            "clinical_significance": "Sensitive",
            "drug": "Gefitinib",
            "tier_level": "Tier I",
            "reference": "PMID:15998907"
          }
        ]
      },
      {
        "name": "Lung Adenocarcinoma",
        "nb_patients": 15,
        "tier_level": "Tier II",
        "age_distribution": {
          "<40": 0,
          "41-60": 3,
          "61-80": 10,
          ">80": 2
        },
        "gender_balance": {
          "male": 10,
          "female": 5
        },
        "pathogenicity": "",
        "pathogenicity_level": "expert",
        "SVIP_status": "Reviewed",
        "clinical_significance": "Predictive (Tier II)",
        "significance_label": "A",
        "score": 4,
        "evidences": [
          {
            "evidence_type": "Predictive",
            "clinical_significance": "Sensitive",
            "drug": "Erlotinib",
            "tier_level": "Tier II",
            "reference": "PMID:25521405"
          }
        ]
      }
    ]
  },
  {
    "gene_name": "EGFR",
    "variant_name": "T790M",
    "HGVScoding": "NM_005228.4:c.2369C>T",
    "HGVSprotein": "NP_005219.2:p.Thr790Met",
    "position": "GrCh37:chr7:55249071",
    "molecular_consequence": "NON_SYNONYMOUS, NONCODING_CHANGE, REGULATORY",
    "dbSNP": "rs121434569",
    "SVIP_status": "Loaded",
    "SVIP_confidence_score": 3,
    "diseases": [
      {
        "name": "Non-Small Cell Lung Carcinoma",
        "nb_patients": 2,
        "tier_level": "Tier I",
        "age_distribution": {
          "<40": 0,
          "41-60": 1,
          "61-80": 1,
          ">80": 0
        },
        "gender_balance": {
          "male": 2,
          "female": 0
        },
        "pathogenicity": "",
        "pathogenicity_level": "automatic",
        "SVIP_status": "Curated",
        "clinical_significance": "Predictive (Tier I)",
        "significance_label": "B",
        "score": 3,
        "evidences": [
          {
            "evidence_type": "Predictive",
            "clinical_significance": "Sensitive",
            "drug": "Osimertinib",
            "tier_level": "Tier I",
            "reference": "PMID:26729184"
          }
        ]
      },
      {
        "name": "Lung Adenocarcinoma",
        "nb_patients": 1,
        "tier_level": "Tier II",
        "age_distribution": {
          "<40": 0,
          "41-60": 1,
          "61-80": 0,
          ">80": 0
        },
        "gender_balance": {
          "male": 0,
          "female": 1
        },
        "pathogenicity": "",
        "pathogenicity_level": "expert",
        "SVIP_status": "Curated",
        "clinical_significance": "Predictive (Tier II)",
        "significance_label": "A",
        "score": 3,
        "evidences": [
          {
            "evidence_type": "Predictive",
            "clinical_significance": "Resistance",
            "drug": "Erlotinib, Gefitinib",
            "tier_level": "Tier II",
            "reference": "PMID:23470965"
          }
        ]
      }
    ]
  }
]
